View in EDS

Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity.

Saved in:
Bibliographic Details
Title: Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity.
Authors: Jokic V; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Savic-Vujovic K; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Spasic J; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Stanic N; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Marinkovic M; Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Radosavljevic D; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Cavic M; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2021 Jun; Vol. 21 (6), pp. 673-679. Date of Electronic Publication: 2021 Mar 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33606592
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jokic+V%22">Jokic V</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Savic-Vujovic+K%22">Savic-Vujovic K</searchLink>; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Spasic+J%22">Spasic J</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Stanic+N%22">Stanic N</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Marinkovic+M%22">Marinkovic M</searchLink>; Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Radosavljevic+D%22">Radosavljevic D</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Cavic+M%22">Cavic M</searchLink>; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101123358%22">Expert review of anticancer therapy</searchLink> [Expert Rev Anticancer Ther] 2021 Jun; Vol. 21 (6), pp. 673-679. <i>Date of Electronic Publication: </i>2021 Mar 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101123358 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8328 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737140%22">14737140 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anticancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33606592
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737140.2021.1893694
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 673
    Titles:
      – TitleFull: Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jokic V
      – PersonEntity:
          Name:
            NameFull: Savic-Vujovic K
      – PersonEntity:
          Name:
            NameFull: Spasic J
      – PersonEntity:
          Name:
            NameFull: Stanic N
      – PersonEntity:
          Name:
            NameFull: Marinkovic M
      – PersonEntity:
          Name:
            NameFull: Radosavljevic D
      – PersonEntity:
          Name:
            NameFull: Cavic M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8328
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Expert review of anticancer therapy
              Type: main
ResultId 1